ONC FY 2022 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

FY 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$1.4B+20.4% YoY

Gross Profit

$1.1B79.8% margin

Operating Income

-$1.8B-126.4% margin

Net Income

-$2.0B-141.5% margin

EPS (Diluted)

$-19.37

Cash Flow

Operating Cash Flow

-$1.5B

Free Cash Flow

-$2.0B

Stock-Based Comp.

$303M

Balance Sheet

Total Assets

$6.4B

Total Liabilities

$2.0B

Stockholders' Equity

$4.4B

Cash & Equivalents

$3.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.2B	+20.4%
Gross Profit	$1.1B	$1.0B	+11.7%
Operating Income	-$1.8B	-$1.4B	-24.4%
Net Income	-$2.0B	-$1.5B	-37.5%